(Q48330963)

10 February 2018

title

Safety of hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol. (English)

1 reference

10 February 2018

beclomethasone dipropionate

main subject

1 reference

P J Thompson

1

1 reference

10 February 2018

R J Davies

2

1 reference

10 February 2018

W F Young

3

1 reference

10 February 2018

A B Grossman

4

1 reference

10 February 2018

D Donnell

5

1 reference

10 February 2018

publication date

1 June 1998

1 reference

10 February 2018

published in

Respiratory Medicine

1 reference

10 February 2018

volume

92 Suppl A

1 reference

10 February 2018

page(s)

33-39

1 reference

10 February 2018

New perspectives on inhaled drug delivery and systemic bioactivity

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990215-3

7 January 2021

Beclomethasone dipropionate. A reappraisal of its pharmacodynamic properties and therapeutic efficacy after a decade of use in asthma and rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990215-3

7 January 2021

Metered-dose inhalers and CFCs: what respiratory physicians need to know

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990215-3

7 January 2021

Twenty-eight-day double-blind safety study of an HFA-134a inhalation aerosol system in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990215-3

7 January 2021

Improved delivery of inhaled steroids to the large and small airways

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990215-3

7 January 2021

Clinical pharmacology of corticosteroids in bronchial asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990215-3

7 January 2021

Fluticasone propionate--an update on preclinical and clinical experience

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990215-3

7 January 2021

Metered-dose inhaler adherence in a clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990215-3

7 January 2021

The adult patient's difficulties with inhalers

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990215-3

7 January 2021

Assessing the use of metered dose inhalers by adults with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990215-3

7 January 2021

Dose-response of inhaled drugs in asthma. An update

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990215-3

7 January 2021

Adverse effects of inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990215-3

7 January 2021

Hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990215-3

7 January 2021

10.1016/S0954-6111(98)90215-3

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018